Health Catalyst, Inc. (NASDAQ:HCAT) Q1 2023 Earnings Conference Call May 9, 2023 5:00 PM ET
Company Participants
Adam Brown - Senior Vice President, Finance and Investor Relations
Dan Burton - Chief Executive Officer
Bryan Hunt - Chief Financial Officer
Conference Call Participants
Anne Samuel - JPMorgan
Jared Haase - William Blair
Jessica Tassan - Piper Sandler
Elizabeth Anderson - Evercore ISI
Anna Kruszenski - SVB Securities
Richard Close - Canaccord Genuity
Daniel Grosslight - Citi
John Ransom - Raymond James
Thomas Kelliher - RBC Capital Markets
David Larsen - BTIG
Jack Wallace - Guggenheim Securities
Scott Schoenhaus - Keybanc Capital
Operator
Welcome to the Health Catalyst First Quarter 2023 Earnings Conference Call. At this time, all participants have been placed on a listen-only mode and the floor will be open for your questions following the presentation. [Operator Instructions]
I would now like to turn the call over to Adam Brown, Senior Vice President of FP&A and Investor Relations.
Adam Brown
Good afternoon, and welcome to Health Catalyst's earnings conference call for the first quarter of 2023, which ended on March 31, 2023. My name is Adam Brown. I'm the Senior Vice President of Investor Relations and Financial Planning and Analysis for Health Catalyst. And with me on the call is Dan Burton, our Chief Executive Officer; and Bryan Hunt, our Chief Financial Officer. A complete disclosure of our results can be found in our press release issued today as well as in our related Form 8-K furnished to the SEC, both of which are available on the Investor Relations section of our website at ir.healthcatalyst.com.
As a reminder, today's call is being recorded, and a replay will be available following the conclusion of the call. During today's call, we will make forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 regarding trends, strategies, the impact of the macroeconomic challenges, including high levels of inflation and high interest rates, the tight labor market, our pipeline conversation rates and the general anticipated performance of the business.
These forward-looking statements are based on management's current views and expectations as of today and should not be relied upon as representing our views as of any subsequent date. We disclaim any obligation to update any forward-looking statements or outlook. Actual results may materially differ. Please refer to the risk factors in our Form 10-K for the full year 2022 filed with the SEC on February 28, 2023, and our Form 10-K for the first quarter 2023 that will be filed with the SEC.